Adams Wealth Management Trims CLOA Position Amid 2025 Filing
A quarterly filing reveals Adams Wealth Management reduced its holdings in the iShares AAA CLO Active ETF (CLOA). The...
Will A Credit Builder Loan Improve Loan Approvals
Wondering if a credit builder loan will improve loan approvals? We explain how these loans impact credit scores and lender perceptions.
14,244 articles$1,000? This Blockbuster Fintech Stock Near $15
Pagaya Technologies posted stronger-than-expected Q1 results, raised full-year guidance, and trades below $14, presen...
3 Ways Fund Your First Real Estate Deal Without 20% Down
If you’re itching to buy your first rental but dread the 20% down barrier, you’re not alone. This guide shares three ...
Deficit Climbing $3.4 Trillion Keeps Mortgage Rates High
A mounting deficit of $3.4 trillion is shaping long-term borrowing costs, with the 30-year fixed mortgage lingering n...
Market Crash: Financial Stocks I’d Buy Without Hesitation
Market turbulence can unveil compelling buying opportunities. Learn why market crash: financial stocks deserve a plac...
AI Won't Make Residential Land Development Easy Right Now
Lenders and developers are embracing AI, yet the path to residential land remains blocked by entitlements, infrastruc...
Five Referral Partners Every Loan Officer Needs in 2026
As rates stabilize in Q1 2026, loan officers are expanding beyond a single source to build a resilient pipeline by wo...
Mungo Appoints Rojas President of Mid-Atlantic Region
Mungo Homes has named Ric Rojas president of its newly formed Mid-Atlantic region, a move designed to accelerate grow...
SPDR Health Care Tops: Long-Term Returns Edge vs IBB
Healthcare investing offers stability and growth potential in one package. This article compares SPDR Health Care (XL...
This Underrated Factor Could Decide the Robotaxi Race Today
Robotaxi headlines often focus on sensors, AI, and fleet size. The real winner may hinge on an overlooked driver. Thi...
Prediction: Pfizer Will Beat the Market in Five Years
Pfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status